Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Benefits, limits and safety aspects

Phytotherapy for cardiovascular diseases

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • Pharmaceutical medicine
    • Phytotherapy
    • Studies
  • 8 minute read

Herbal preparations and “natural” dietary supplements are frequently used by patients with cardiovascular disease – often in the hope of “gently” influencing blood pressure, lipids or symptoms. However, guidelines from European and American professional societies unanimously emphasize that phytotherapeutics and dietary supplements should not replace established lifestyle and pharmacotherapy. In particular, the 2025 focused ESC/EAS update on dyslipidemia therapy concludes, after reviewing the available evidence, that there is insufficient evidence for any supplement that lowers LDL cholesterol while improving cardiovascular risk with reasonable safety.

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten
Already a member? Log in here
Autoren
  • Tanja Schliebe
Publikation
  • PHYTOTHERAPIE PRAXIS
Related Topics
  • ESC/EAS
  • Focus adjustment
  • Food supplement
  • LDL cholesterol
  • red rice
Previous Article
  • Results of the FOREST HCM study

Symptomatic obstructive hypertrophic cardiomyopathy

  • RX
  • Cardiology
  • Education
  • Studies
View Post
Next Article
  • Digital biomarkers

Continuous monitoring using digital biomarkers in MS care

  • RX
  • Education
  • Neurology
  • Studies
View Post
You May Also Like
View Post
  • 7 min
  • Pediatric Retinoblastoma

The Tumor Microenvironment and Modern Eye-Sparing Therapies

    • RX
    • Education
    • Oncology
    • Ophthalmology
    • Pediatrics
View Post
  • 3 min
  • Adherence and management in asthma and COPD

Better to listen to the pharmacist

    • RX
    • Education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Pneumology
    • Studies
View Post
  • 14 min
  • Focus Update 2026

Echocardiography in Cardio-Oncology

    • RX
    • Cardiology
    • Education
    • Oncology
    • Radiology
    • Studies
View Post
  • 4 min
  • Physical activity with IBD

Sport is not murder, but it doesn’t help either

    • RX
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Sports Medicine
    • Studies
View Post
  • 3 min
  • White and Black Skin Cancer

Biology and Modern Therapeutic Approaches

    • RX
    • Dermatology and venereology
    • Education
    • Oncology
    • Prevention and health care
    • Studies
    • Surgery
View Post
  • 5 min
  • Highlights from the AAD Annual Meeting

Atopic Dermatitis: Interesting News on Drug Candidates in Phase III

    • RX
    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Studies
View Post
  • 6 min
  • Autoimmune Liver Diseases

Innovative Treatment Approaches for PBC, PSC, and AIH: What’s New?

    • RX
    • Congress Reports
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Studies
View Post
  • 8 min
  • Myelofibrosis

Mutations and Molecular Diagnostics in Treatment Decisions

    • RX
    • Education
    • Hematology
    • Oncology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.